Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic Health.

Facco, Francesca L; Redline, Susan; Hunter, Shannon M; Zee, Phyllis C; Grobman, William A; Silver, Robert M; Louis, Judette M; Pien, Grace W et al. · Am J Respir Crit Care Med · 2022

prospective_cohort · Level II

Where this comes from

Abstract

<b>Rationale:</b> Knowledge gaps exist regarding health implications of sleep-disordered breathing (SDB) identified in pregnancy and/or after delivery. <b>Objectives:</b> To determine whether SDB in pregnancy and/or after delivery is associated with hypertension (HTN) and metabolic syndrome (MS). <b>Methods:</b> nuMoM2b-HHS (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be Heart Health Study) (<i>N</i> = 4,508) followed participants initially recruited during their first pregnancy. Participants returned for a visit 2-7 years after pregnancy. This study examined a subgroup who underwent SDB assessments during their first pregnancy (<i>n</i> = 1,964) and a repeat SDB assessment after delivery (<i>n</i> = 1,222). Two SDB definitions were considered: <i>1</i>) apnea-hypopnea index (AHI) ⩾ 5 and <i>2</i>) oxygen desaturation index (ODI) ⩾ 5. Associations between SDB and incident HTN and MS were evaluated with adjusted risk ratios (aRRs). <b>Measurements and Main Results:</b> The aRR for MS given an AHI ⩾ 5 during pregnancy was 1.44 (95% confidence interval [CI], 1.08-1.93), but no association with HTN was found. ODI ⩾ 5 in pregnancy was associated with both an increased risk for HTN (aRR, 2.02; 95% CI, 1.30-3.14) and MS (aRR, 1.53; 95% CI, 1.19-1.97). Participants with an AHI ⩾ 5 in pregnancy that persisted after delivery were at higher risk for both HTN (aRR, 3.77; 95% CI, 1.84-7.73) and MS (aRR, 2.46; 95% CI, 1.59-3.76). Similar associations were observed for persistent ODI ⩾ 5 after delivery. <b>Conclusions:</b> An AHI ⩾ 5 in pregnancy was associated with an increased risk of MS. An ODI ⩾ 5 in pregnancy was significantly associated with both HTN and MS. Participants with persistent elevations in AHI and ODI during pregnancy and at 2-7 years after delivery were at the highest risk for HTN and MS. Clinical trial registered with www.clinicaltrials.gov (NCT02231398).

Medical subject headings